Richard L Sidman Selected Research

1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)

3/2021	Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
1/2020	Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
10/2019	Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer.
11/2016	Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.
11/2016	Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.
3/2016	AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard L Sidman Research Topics

Disease

33	Neoplasms (Cancer) 11/2021 - 02/2004
8	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2011
7	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 02/2015
4	Inflammation (Inflammations) 12/2020 - 12/2004
4	Parkinson Disease (Parkinson's Disease) 01/2017 - 07/2007
3	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2015
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2011
3	Synucleinopathies 01/2017 - 07/2011
3	Hypoxia (Hypoxemia) 02/2014 - 02/2004
2	COVID-19 03/2021 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020 - 10/2004
2	Nervous System Diseases (Neurological Disorders) 01/2018 - 01/2017
2	Memory Disorders (Memory Loss) 01/2017 - 07/2011
2	Melanoma (Melanoma, Malignant) 02/2016 - 02/2015
2	Lung Neoplasms (Lung Cancer) 01/2016 - 03/2015
2	Retinal Diseases 10/2015 - 10/2007
2	Obesity 02/2013 - 01/2013
2	Spinal Cord Injuries (Spinal Cord Injury) 02/2013 - 11/2006
2	Genomic Instability 03/2011 - 09/2003
2	Carcinogenesis 09/2010 - 03/2010
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 03/2010 - 10/2007
1	Brain Concussion (Cerebral Concussion) 01/2022
1	Severe Acute Respiratory Syndrome 03/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Microsatellite Instability 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2017
1	Disease Progression 01/2017

Drug/Important Bio-Agent (IBA)

18	LigandsIBA 03/2021 - 10/2007
11	Peptides (Polypeptides)IBA 03/2021 - 02/2004
10	Pharmaceutical PreparationsIBA 01/2021 - 03/2010
6	1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)IBA 03/2021 - 03/2016
6	Peptide LibraryIBA 10/2016 - 02/2004
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2015
5	Endoplasmic Reticulum Chaperone BiPIBA 01/2018 - 03/2015
5	PeptidomimeticsIBA 01/2017 - 10/2007
4	Biological ProductsIBA 01/2021 - 12/2007
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2015
3	Monoclonal AntibodiesIBA 01/2018 - 02/2004
3	Cell Surface ReceptorsIBA 01/2017 - 10/2016
3	SynucleinsIBA 01/2017 - 07/2011
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2017 - 07/2011
2	VaccinesIBA 03/2021 - 01/2021
2	CytokinesIBA 01/2021 - 02/2016
2	IntegrinsIBA 01/2020 - 11/2011
2	LithiumIBA 01/2018 - 01/2017
2	Long Noncoding RNAIBA 10/2017 - 07/2015
2	UbiquitinIBA 01/2017 - 07/2011
2	Myeloblastin (Proteinase 3)IBA 01/2017 - 11/2011
2	Annexin A2 (Annexin II)IBA 01/2017 - 11/2011
2	Serine Proteases (Serine Protease)IBA 01/2017 - 10/2004
2	bone metastasis-targeting peptidomimetic-11IBA 01/2017 - 01/2016
2	Interleukin-11 Receptors (Interleukin 11 Receptor)IBA 01/2017 - 01/2016
2	Ganciclovir (Cytovene)FDA LinkGeneric 11/2016 - 09/2016
2	Thymidine KinaseIBA 11/2016 - 01/2011
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2016 - 02/2016
2	Retinaldehyde (Retinal)IBA 10/2015 - 10/2007
2	Indicators and Reagents (Reagents)IBA 02/2015 - 03/2007
2	Oxygen (Dioxygen)IBA 02/2014 - 03/2007
2	CD13 Antigens (Alanine Aminopeptidase)IBA 12/2013 - 01/2012
2	GlycogenIBA 06/2013 - 08/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2013 - 01/2013
2	AcidsIBA 12/2008 - 08/2008
1	6-(trifluoroacetamido)-1-hexanoicanilideIBA 01/2022
1	Cyclic PeptidesIBA 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2021
1	Protein Disulfide-IsomerasesIBA 01/2021
1	EnzymesIBA 12/2020
1	ChemokinesIBA 12/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	MutL Protein Homolog 1IBA 01/2018
1	CarbohydratesIBA 01/2018
1	alovudineIBA 01/2018
1	AntibodiesIBA 01/2018
1	ceramide glucosyltransferaseIBA 01/2017
1	quinuclidin- 3- yl- N- (1- (3- (4- fluorophenyl)phenyl)- 1- methyl- ethyl)carbamateIBA 01/2017
1	Interleukin-11 (Interleukin 11)IBA 01/2017
1	Immunoglobulin FragmentsIBA 11/2016
1	Small Interfering RNA (siRNA)IBA 11/2016
1	ProdrugsIBA 11/2016
1	Coloring Agents (Dyes)IBA 10/2016
1	Single-Chain AntibodiesIBA 10/2016
1	Lipid Bilayers (Lipid Bilayer)IBA 10/2016
1	Octreotide (Sandostatin)FDA LinkGeneric 03/2016
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2016
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2016
1	Insulin (Novolin)FDA Link 03/2016

Therapy/Procedure

14	Therapeutics 11/2021 - 06/2006
3	Precision Medicine 01/2021 - 10/2016
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2017
2	Transplantation 03/2011 - 03/2010
1	Immunotherapy 11/2021
1	Aftercare (After-Treatment) 01/2020
1	Castration 11/2016
1	Intraperitoneal Injections 09/2016